SEED AND GROWTH STAGE FUND RAISING

The choice of a suitable investor is crucial for the future development of your company. Our experience encompasses launching new innovative ventures to refinancing public entities.

	We challenge and develop your business plan
	We advise you on intellectual property
	We support you in planning, preparing and raising capital
	We organize the approach to investors
	We support you in negotiating financing terms

Mikael Ørum
Founder & Partner
Collectively, Ventac Partners team has been responsible for the raising of more than US$ 150 million in risk capital to life sciences businesses during the last fifteen years, ranging from the seed stage through the various stages of growth funding. In companies co-founded by partners more than US$ 300 million have been injected to stimulate growth, deal making, partnering and exits, including listing in the stock exchange.

In 2010-11, Ventac Partners has been at the helmet of transactions into young biotech companies in Europe and the US , totaling more than US$ 6 million.

Importantly, Ventac Partners have developed special expertise in helping companies make successful applications for public funding programs in a range of countries globally. Through the last six years, companies – with the help of Ventac Partners – have raised more than US$ 12 million in soft money programs to stimulate R&D projects.